Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2020 Nov 7;396(10261):1488.
doi: 10.1016/S0140-6736(20)32268-6.

Early triple antiviral therapy for COVID-19 - Authors' reply

Ivan Fan-Ngai Hung  1 , Kwok-Yung Yuen  2
Affiliations
Comment

Early triple antiviral therapy for COVID-19 - Authors' reply

Ivan Fan-Ngai Hung et al. Lancet. .
No abstract available

PubMed Disclaimer

Comment on

References

    1. Hung IF, Lung KC, Tso EY. Triple combination of interferon beta-1b, lopinavir-ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trial. Lancet. 2020;395:1695–1704. - PMC - PubMed
    1. Yuan S, Chan CC, Chik KK. Broad-spectrum host-based antivirals targeting the interferon and lipogenesis pathways as potential treatment options for the pandemic coronavirus disease 2019 (COVID-19) Viruses. 2020;12:628. - PMC - PubMed
    1. Chu CM, Cheng VC, Hung IF. Role of lopinavir/ritonavir in the treatment of SARS: initial virological and clinical findings. Thorax. 2004;59:252–256. - PMC - PubMed
    1. Chan JF, Yao Y, Yeung ML. Treatment with lopinavir/ritonavir or interferon-β1b improves outcome of MERS-CoV infection in a nonhuman primate model of common marmoset. J Infect Dis. 2015;212:1904–1913. - PMC - PubMed
    1. Cao B, Wang Y, Wen D. A trial of lopinavir-ritonavir in adults hospitalized with severe covid-19. N Engl J Med. 2020;382:1787–1799. - PMC - PubMed